Genentech posts update on phase III study of Avastin
Thursday, April 24, 2008 14:00 IST South San Francisco, California
Genentech, Inc. posted an update for the previously reported Roche-sponsored international phase III clinical study (AVAiL) of Avastin (bevacizumab) in combination with gemcitabine and cisplatin chemotherapy,